- Home
- DJCO vs PGEN Comparison
DJCO vs PGEN Comparison
Compare DJCO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJCO
- PGEN
- Stock Information
- Founded
- DJCO 1987
- PGEN 1998
- Country
- DJCO United States
- PGEN United States
- Employees
- DJCO N/A
- PGEN N/A
- Industry
- DJCO Newspapers/Magazines
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- DJCO Consumer Discretionary
- PGEN Health Care
- Exchange
- DJCO Nasdaq
- PGEN Nasdaq
- Market Cap
- DJCO 571.5M
- PGEN 493.0M
- IPO Year
- DJCO N/A
- PGEN N/A
- Fundamental
- Price
- DJCO $445.87
- PGEN $3.59
- Analyst Decision
- DJCO
- PGEN Buy
- Analyst Count
- DJCO 0
- PGEN 5
- Target Price
- DJCO N/A
- PGEN $7.50
- AVG Volume (30 Days)
- DJCO 62.2K
- PGEN 10.4M
- Earning Date
- DJCO 08-14-2025
- PGEN 11-13-2025
- Dividend Yield
- DJCO N/A
- PGEN N/A
- EPS Growth
- DJCO 115.36
- PGEN N/A
- EPS
- DJCO 70.22
- PGEN N/A
- Revenue
- DJCO $79,159,000.00
- PGEN $4,340,000.00
- Revenue This Year
- DJCO N/A
- PGEN $253.63
- Revenue Next Year
- DJCO N/A
- PGEN $699.64
- P/E Ratio
- DJCO $5.81
- PGEN N/A
- Revenue Growth
- DJCO 10.54
- PGEN N/A
- 52 Week Low
- DJCO $359.34
- PGEN $0.65
- 52 Week High
- DJCO $602.00
- PGEN $5.23
- Technical
- Relative Strength Index (RSI)
- DJCO 48.28
- PGEN 49.90
- Support Level
- DJCO $406.77
- PGEN $3.89
- Resistance Level
- DJCO $502.30
- PGEN $5.23
- Average True Range (ATR)
- DJCO 18.06
- PGEN 0.34
- MACD
- DJCO -6.68
- PGEN -0.16
- Stochastic Oscillator
- DJCO 40.93
- PGEN 6.82
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.